Skip to main content
OpenTrials

Clinical trial condition

Amyloid Neuropathies

Explore clinical trials studying Amyloid Neuropathies. Study availability and eligibility vary by location and protocol.

132 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Amyloid Neuropathies trial results

Active, not recruiting

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

NCT04988386

Conditions
Amyloid Cardiomyopathy, Transthyretin-Related, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +13 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Hospital - Anschutz Medical Campus Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 72 locations
View Trial Details
Active, not recruiting

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

NCT07062848

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +13 more
Locations
  • University of California - San Francisco (UCSF) Health San Francisco, California, United States
  • Yale New Haven Health System New Haven, Connecticut, United States
  • Henry Ford Health Detroit, Michigan, United States
  • Mount Sinai New York, United States
View Trial Details
Active, not recruiting

Open-Label Study of AG10 in Patients with Cardiomyopathy

NCT03536767

Conditions
Amyloid Cardiomyopathy, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +13 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

NCT05184088

Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations
  • St Luke's Hospital Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Augsburg Augsburg, Germany
View all 14 locations
View Trial Details

Related conditions